The Impact of Phototherapy on the modification of Fatigue and Cognitive functions for patients with Relapsing Remitting Multiple Sclerosis.
- Conditions
- Fatigue caused by Multiple sclerosisStress reaction tolerance (cognitive function), of patients with Multiple sclerosisMultiple SclerosisNeurological - Multiple sclerosisPhysical Medicine / Rehabilitation - PhysiotherapyMental Health - Studies of normal psychology, cognitive function and behaviour
- Registration Number
- ACTRN12614001025628
- Lead Sponsor
- Shimaa Essa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
1- During remission state, regardless of the duration of Multiple Sclerosis (MS) established diagnosis, with less than or equal to score (6) on the EDSS scale.
2- Patients free from any systemic vascular or blood disease, vasculitis, diabetes, liver disease, kidney failure, heart failure, traumatic brain injury (TBI), cerebrovascular accident (CVA), spinal cord injury (SCI), human immunosuppressive virus (HIV), hyperthyrodism, cancer or in risk of chemical or atomic radiation exposure.
3- Patients with skin type of grade 3 or 4 only.
1- Female patients who get pregnant or other patients who develop an allergic reaction to phototherapy or go into an MS relapse were excluded of the study.
2- Patients who miss more than 3 successive sessions will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue severity, using the Fatigue Severity Scale (FSS)[Baseline and by the end of the 4 week treatment program];Stress reaction tolerance, through S1 adaptive Determination Test (DT) of the computerized Vienna system.[Baseline and by the end of the 4 week treatment program]
- Secondary Outcome Measures
Name Time Method Disability status, through using the Expanded Disability Status Scale (EDSS) [Baseline and by the end of the 4 week treatment program]